Antibodies play a vital role in research as powerful tools for studying protein interactions and signaling pathways. They are widely used in various experimental techniques to detect, isolate, and characterize specific proteins of interest. Here are some ways antibodies are used in research:
Immunofluorescence
Immunofluorescence is a technique commonly used for protein detection by visualizing protein interactions and confirming cellular localizations. Antibodies that selectively bind to target proteins of interest are tagged with a fluorescent dye. For specific staining, several proteins are labelled with antibodies linked to different fluorophores, and confocal microscopy is used. If the merging of images reveals an overlapping signal, this indicates protein co-localization.
Immunoprecipitation
By immobilizing antibodies on solid supports, such as agarose or magnetic beads, proteins of interest can be captured from cells or tissue extracts. This enables the precipitation of proteins that are in a complex or in contact with a protein of interest, and allows for further isolation and purification for analyses.
Co-immunoprecipitation
Antibodies can also serve as probes to identify interacting partners. Co-immunoprecipitation use antibodies to capture a target protein and its associated interactors from a sample, revealing not only the interaction between the two proteins, but also the strength of interaction under different circumstances.1
Here at Biointron, we are dedicated to accelerating antibody discovery, optimization, and production. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.
Erbil-Bilir, S., Kocaturk, N. M., Yayli, M., & Gozuacik, D. (2016). Study of Protein-protein Interactions in Autophagy Research. Journal of Visualized Experiments : JoVE, (127). https://doi.org/10.3791/55881
DOI: 10.3389/fbioe.2022.856049Antibodies have become essential tools for the diagnosis and treatment of numerous human diseases. However, non-human antibodies, such as those derived from murine sources, often provoke human anti-mouse antibody (HAMA) responses. This immunogenicity leads to rapid clea
In therapeutic antibody development, achieving high-affinity antigen binding is central to improving drug efficacy, durability, and safety.Biointron’s High-Throughput Fully Human Antibody Discovery service is designed to meet this need by integrating advanced screening and engineering technol
I. Introduction to Hybridoma TechnologyHybridoma technology, developed by Köhler and Milstein in 1975, is a foundational method for producing monoclonal antibodies (mAbs). The approach involves fusing antibody-producing B lymphocytes with immortal myeloma cells to form hybridoma cells. These hybrid
Introduction to Monoclonal Antibody Discovery Monoclonal antibodies (mAbs) are one of the most successful classes of biologic drugs on the global pharmaceutical market. Since the approval of Orthoclone OKT3 in 1986, over 100 mAbs have been approved by the U.S. FDA for indications incl